FR1444M - New drug especially for the treatment of ovarian irregularities and insufficiencies. - Google Patents

New drug especially for the treatment of ovarian irregularities and insufficiencies.

Info

Publication number
FR1444M
FR1444M FR869787A FR869787A FR1444M FR 1444 M FR1444 M FR 1444M FR 869787 A FR869787 A FR 869787A FR 869787 A FR869787 A FR 869787A FR 1444 M FR1444 M FR 1444M
Authority
FR
France
Prior art keywords
insufficiencies
ovarian
irregularities
treatment
new drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR869787A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR869787A priority Critical patent/FR1444M/en
Priority to SE470362A priority patent/SE301967B/xx
Priority to CH510562A priority patent/CH411853A/en
Priority to ES276968A priority patent/ES276968A1/en
Priority to BE617259A priority patent/BE617259A/en
Priority to GB1729162A priority patent/GB976727A/en
Application granted granted Critical
Publication of FR1444M publication Critical patent/FR1444M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
FR869787A 1961-05-04 1961-08-02 New drug especially for the treatment of ovarian irregularities and insufficiencies. Active FR1444M (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR869787A FR1444M (en) 1961-05-04 1961-08-02 New drug especially for the treatment of ovarian irregularities and insufficiencies.
SE470362A SE301967B (en) 1961-05-04 1962-04-26
CH510562A CH411853A (en) 1961-05-04 1962-04-27 Process for the preparation of estradiol derivatives
ES276968A ES276968A1 (en) 1961-05-04 1962-05-03 Procedure for the preparation of (9-beta) estradiol (Machine-translation by Google Translate, not legally binding)
BE617259A BE617259A (en) 1961-05-04 1962-05-04 Estradiol derivatives and method of preparation
GB1729162A GB976727A (en) 1961-05-04 1962-05-04 Novel estradiol derivatives, processes for their preparation and pharmaceutical compositions incorporating the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR860746A FR1368727A (en) 1961-05-04 1961-05-04 Estradiol derivatives and method of preparation
FR869787A FR1444M (en) 1961-05-04 1961-08-02 New drug especially for the treatment of ovarian irregularities and insufficiencies.

Publications (1)

Publication Number Publication Date
FR1444M true FR1444M (en) 1962-08-13

Family

ID=8754452

Family Applications (2)

Application Number Title Priority Date Filing Date
FR860746A Expired FR1368727A (en) 1961-05-04 1961-05-04 Estradiol derivatives and method of preparation
FR869787A Active FR1444M (en) 1961-05-04 1961-08-02 New drug especially for the treatment of ovarian irregularities and insufficiencies.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR860746A Expired FR1368727A (en) 1961-05-04 1961-05-04 Estradiol derivatives and method of preparation

Country Status (2)

Country Link
US (1) US3198707A (en)
FR (2) FR1368727A (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
LT2782584T (en) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Also Published As

Publication number Publication date
FR1368727A (en) 1964-08-07
US3198707A (en) 1965-08-03

Similar Documents

Publication Publication Date Title
FR1444M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR2609M (en) New drug for the treatment of staphylococcal and streptococcal infections.
FR362M (en) New drug for the treatment of staphylococcal infections and salmonellosis.
BE582173A (en) Advanced device for the treatment of threads.
FR2802M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR3187M (en) New drug in particular for the treatment of irregularities and ovarian insufficiencies.
FR1172M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR365M (en) New drug for the treatment of staphylococcal and streptococcal infections.
FR2743M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR363M (en) New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.
FR2193M (en) New drug for the treatment of infectious diseases.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR2510M (en) New medicament usable for the treatment of staphylococcal infections and the like.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1338926A (en) Furnace for the treatment of strips
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR33F (en) New drug for the treatment of staphylococcal infections and the like.
FR1388164A (en) Products for the treatment of nails and hair
FR3744M (en) Drugs for the treatment of psychiatric conditions.
FR1039M (en) Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses.
FR28F (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.